GLP-1(7-37) significantly stimulated insulin secretion, suggesting it plays an important role in insulin secretion (Mojsov et al 1987)
CJC-1295 (Mod GRF 1-29) (Mod GRF 1-29), Ipamorelin, GHRP-2 Blend, and Bone Mass By apparently increasing growth hormone synthesis, all three peptides may potentially upregulate bone mineral density
Ilahi S, Beriwal N, Ilahi TB (2023) Physiology, Pineal Gland
A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone
No purchase is available today